Resmed (RSMDF) Inventory (2010 - 2026)

Resmed has reported Inventory for 17 years, with the latest figure at $911.9 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 5.71% year-over-year to $911.9 million; the trailing twelve-month figure through Mar 2026 stood at $911.9 million (up 5.71% YoY), and the FY2025 full-year result was $927.7 million, up 12.83% from the prior year.
• Inventory for Q1 2026 stood at $911.9 million, down from $922.0 million in the prior quarter.
• The five-year high for Inventory was $1.0 billion in Q1 2023, with the low at $664.9 million in Q1 2022.
• Historically, Inventory has averaged $893.3 million across 5 years, with a median of $918.0 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory surged 70.7% — and 2024, when it retreated 17.98%.
• Resmed's Inventory stood at $989.0 million in 2022, then slipped by 5.64% to $933.2 million in 2023, then slipped by 5.48% to $882.1 million in 2024, then advanced by 4.53% to $922.0 million in 2025, then dropped by 1.1% to $911.9 million in 2026.
• The last three Inventory figures came in at $911.9 million (Q1 2026), $922.0 million (Q4 2025), and $945.8 million (Q3 2025), per Business Quant data.